» Authors » Marinela Contreras

Marinela Contreras

Explore the profile of Marinela Contreras including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 734
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaz-Rodrigues R, Mazuecos L, Contreras M, Gonzalez-Garcia A, Rafael M, Villar M, et al.
Sci Rep . 2025 Mar; 15(1):8849. PMID: 40087469
The alpha-Gal syndrome (AGS) evolved as a catastrophic selection associated with anti-α-Gal IgM/IgG protective response against pathogen infection and tick-borne food allergy caused by IgE-type antibodies against this glycan present...
2.
Contreras M, Rafael M, Sobrino I, Almazan C, Pastor Comin J, Valdes J, et al.
PLoS One . 2025 Feb; 20(2):e0318439. PMID: 39928697
Ticks and tick-borne diseases are a growing burden worldwide and vaccines are effective control interventions. Vaccine formulations with tick antigens such as BM86/BM95 (BM) and Subolesin (SUB) have shown reduction...
3.
de la Fuente J, Gortazar C, Contreras M, Kabi F, Kasaija P, Mugerwa S, et al.
Vaccine . 2025 Jan; 45():126695. PMID: 39765365
No abstract available.
4.
Kasaija P, Kabi F, Semakula J, Kyakuwa I, Contreras M, de la Fuente G, et al.
Vaccine . 2024 Nov; 44:126562. PMID: 39612805
After approval of the Subolesin-based anti-tick vaccine in Uganda, we completed a one-year follow-up evaluation study. The results showed significantly 2.1-5.0-fold higher anti-SUB IgG antibody titers in vaccinated cattle in...
5.
Contreras M, Sobrino I, de la Fuente J
Trends Parasitol . 2024 Oct; 40(12):1107-1114. PMID: 39462754
Tick vaccines are an environmentally friendly intervention for the prevention and control of tick-borne diseases affecting humans and animals worldwide. From our perspective, the challenges in tick vaccinology have encouraged...
6.
de la Fuente J, Ghosh S, Lempereur L, Garrison A, Sprong H, Lopez-Camacho C, et al.
NPJ Vaccines . 2024 Oct; 9(1):181. PMID: 39353956
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease associated with its principal tick vector, Hyalomma spp. with increasing fatal incidence worldwide. Accordingly, CCHF is a World Health Organization-prioritized disease with...
7.
Kabi F, Contreras M, Semakula J, Sanchez-Sanchez M, Munoz-Hernandez C, Mugerwa S, et al.
NPJ Vaccines . 2024 Sep; 9(1):174. PMID: 39294184
Vaccines are the most effective and sustainable intervention to control ticks and tick-borne diseases (TBD). Using a personalized vaccine design based on regional tick genotypes, a Rhipicephalus appendiculatus Subolesin protective...
8.
Sanchez-Sanchez M, Caballero-Gomez J, Munoz-Hernandez C, Moraga-Fernandez A, Fernandez-Veron I, Contreras M, et al.
Prev Vet Med . 2024 Aug; 232:106330. PMID: 39216329
Coxiella burnetii is a multi-host bacterium of major public and animal health concern. This pathogen circulates among several wild species in the Iberian Peninsula, however, the role of the Iberian...
9.
Moraga-Fernandez A, de Sousa-Blanco M, Marques J, Queiros J, Fernandez-Melgar R, Garcia-Alvarez O, et al.
Res Vet Sci . 2024 Aug; 178:105370. PMID: 39116823
There are currently no vaccines available to prevent and control of Anaplasma phagocytophilum, an intracellular bacterial pathogen transmitted by ticks that occurs in many regions of the world and causes...
10.
Vaz-Rodrigues R, Mazuecos L, Villar M, Contreras M, Gonzalez-Garcia A, Bonini P, et al.
Int J Parasitol . 2024 Jul; 54(12):649-659. PMID: 39074655
Ticks, as hematophagous ectoparasites, can manipulate host immune and metabolic processes, causing tick-borne allergies such as α-Gal syndrome (AGS). Glycolipids with bound galactose-alpha-1-3-galactose (α-Gal) are potential allergenic molecules associated with...